Stroke Clinical Trials in Portland, Oregon

4 studies are recruiting for stroke in Portland, Oregon right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)

    This is a Phase 2/3 study evaluating the safety and efficacy of DM199 (rinvecalinase alfa) in treating participants with moderate stroke severity, who present within 24 hours of Acute Ischemic Stroke (AIS) onset due to small and medium vessel occlusions. This study focuses on participants with limi…

    Stage
    Phase 2
    Ages
    18 to 90
    Site
    Oregon Health & Science University, Portland, Oregon
    Locations
    86 in total
    Run by
    DiaMedica Therapeutics Inc

    See if you can join NCT05065216 on ClinicalTrials.gov

  2. CoMind Early Feasibility Study

    The purpose of this research, which has been determined as non-significant risk by the central IRB overseeing the study, is to obtain information to help further develop a machine (a medical device) to measure the pressure around the brain from the outside (this pressure is called intracranial pres…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Oregon Health & Science University, Portland, Oregon
    Locations
    16 in total
    Run by
    CoMind Technologies Limited

    See if you can join NCT06368648 on ClinicalTrials.gov

  3. Treatment With Endovascular Intervention for STroke Patients With Existing Disability

    TESTED will compare the risks and benefits of endovascular thrombectomy (EVT) to medical management (no EVT) in ischemic stroke patients who have a blockage in one of the large blood vessels in the brain and have a moderate-to-severe disability prior to their stroke.

    Stage
    Not phased
    Ages
    18 and older
    Site
    Providence St. Vincent Medical Center, Portland, Oregon
    Locations
    35 in total
    Run by
    University of Cincinnati

    See if you can join NCT05911568 on ClinicalTrials.gov

  4. GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study

    This study will assess the safety and effectiveness of GORE® CARDIOFORM Septal Occluder in a post approval setting and evaluate the quality of operator education and training and transferability of trial experience to a post-market setting.

    Stage
    Not phased
    Ages
    18 to 70
    Site
    Providence Heart & Vascular Institute, Portland, Oregon
    Locations
    45 in total
    Run by
    W.L.Gore & Associates

    See if you can join NCT03821129 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.